SPY240726C552000
- 0.03
- -0.05-62.50%
SPDR S&P 500 ETF Newsroom
Market Opens Green, Economy's Health Suggests 'No Landing' Scenario
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
DoorDash Hires Former Amazon Exec to Expand Delivery Options
Express News | Michigan Consumer Expectations For July 68.8 Vs 67.2 Est.; 69.6 Prior
Express News | Michigan Consumer Sentiment For July 66.4 Vs 66.0 Est.; 68.2 Prior
Express News | Benzinga Market Summary: June PCE At 2.5% YoY In Line With Expectations, 3M Rises On Earnings Report And EPS Outlook Raise, SEC Sues Andrew Left And Citron Over Short Sales
Nvidia, Lockheed Martin And 2 Other Stocks Insiders Are Selling
Bank of America: Technology stocks are only one "terrible non-farm report" away from collapsing.
Since the historical high point on July 10th, the market cap of companies in the Nasdaq 100 index has evaporated $2.6 trillion. Analyst Michael Hartnett of Bank of America believes that signs of an economic slowdown will put further pressure on technology stocks, but remains optimistic on the bond market for the second half of the year.
OpenAI Unveils SearchGPT: A New Challenger to Google's Search Engine Dominance
Microsoft's AI Play Is Silver Lining In Cloudy Quarter: JPMorgan
Fed's Preferred Inflation Measure Shows Mixed Readings, Personal Income, Spending Fall: September Rate Cut Remains Likely
Express News | Personal Spending MoM For June 0.3% Vs 0.3% Expected, 0.4% Prior
Express News | USA Core PCE Price Index (YoY) For June 2.6% Vs 2.5% Est.; 2.6% Prior
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Key Inflation Data
Amazon Tests AI Chips in Texas Lab, Aims to Cut Nvidia Costs
Today's Morning Movers and Top Ratings: AAPL, MMM, NVDA, COIN and More
Riding the NVIDIA Wave, is Serve Robotics worth holding for the long term?
US Stocks Look To End Week On High Note As Nvidia Leads Mega-Caps Higher In Premarket Ahead Of Key Inflation Data
Apple to Adopt AI Protections Set Forth by Biden Administration
Biogen-partnered Alzheimer's Therapy Fails to Clear EU Hurdle